Deliver Your News to the World

CybeRelease: Issues (OTC: IMGM) Update


(CybeRelease, February 23, 2006) - Lake Harmony, PA - issues a trader’s update on Imagin Molecular Corp. (OTC PK: IMGM) after the company closed up $.21 to $.84 on 1,032,970 shares Wednesday. IMGM was added to’s “Stocks to Watch” on January 5th at a price of $.13. IMGM realized a gain of 592% from January 5th when it reached the $.90 mark before closing at $.84 on Wednesday. Congratulations to those of you who follow

Please visit: for an IMGM profile and other stocks to watch.

About Imagin Molecular Corporation:

Imagin Molecular Corporation strategy and focus dedicated to business opportunities in PET manufacturing and the diagnosis of cancer, heart disease and neurological diseases. Imagin Molecular Corporation has positioned the Company to be a factor in PET and ancillary molecular imaging businesses. Imagin Nuclear Partners is a wholly owned subsidiary of Imagin Molecular Corporation is a full-service joint venture molecular imaging partner that will own, operate and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment. PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders including Alzheimer’s disease. INP is a cutting-edge company that specializes in using evidence-based medicine driven by bioinformatics specifically positioned in the market to provide the maximal cost effective benefit to their joint venture partner and the community.

CybeRelease Gainers are The9 Ltd. (Nasdaq: NCTY), VA Software Corp. (Nasdaq: LNUX), Acacia Research Corp. - Combimatrix (Nasdaq: CBMX), Amcor Ltd. (Nasdaq: AMCR), Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI), Cobra Electronics Corp. (Nasdaq: COBR), Genaera Corp. (Nasdaq: GENR) and Silicon Storage Technology Inc. (Nasdaq: SSTI).

CybeRelease Decliners are GTC Biotherapeutics Inc. (Nasdaq: GTCB), MakeMusic Inc. (Nasdaq: MMUS), Bluefly Inc. (Nasdaq: BFLY), KOS Pharmaceuticals Inc. (Nasdaq: KOSP), Reuters Group plc (Nasdaq: RTRSY), Novatel Wireless Inc. (Nasdaq: NVTL), EarthLink Inc. (Nasdaq: ELNK) and Century Aluminum Co. (Nasdaq: CENX).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $495.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.